Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome)

M. Fanaridis (Heraklion, Greece), I. Bouloukaki (Heraklion, Greece), G. Stathakis (Heraklion, Greece), P. Steiropoulos (Alexandroupolisaklion, Greece), E. Mauroudi (Heraklion, Greece), V. Moniaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), S. Schiza (Heraklion, Greece)

Source: Sleep and Breathing Conference 2021
Session: Treatment and management of sleep respiratory diseases
Session type: Oral Presentation
Number: 0
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fanaridis (Heraklion, Greece), I. Bouloukaki (Heraklion, Greece), G. Stathakis (Heraklion, Greece), P. Steiropoulos (Alexandroupolisaklion, Greece), E. Mauroudi (Heraklion, Greece), V. Moniaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), S. Schiza (Heraklion, Greece). Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome). Sleep and Breathing Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: